XML Cancer News

Graphene sensor tracks down cancer biomarkers

published 1 day ago
(Institute of Physics) An ultrasensitive biosensor made from the wonder material graphene has been used to detect molecules that indicate an increased risk of developing cancer.

Patients with advanced, incurable cancer denied palliative care

published 1 day ago
(European Society for Medical Oncology) Many patients with advanced, incurable cancer do not receive any palliative care, reveals new research to be presented later this month at the ESMO 2014 Congress in Madrid, Spain, Sept. 26-30. The findings are astonishing as they come at the same time as 15 new oncology centres in Europe, Canada, South America and Africa are being awarded the prestigious title of 'ESMO Designated Centre of Integrated Oncology and Palliative Care.'

A better way to track emerging cell therapies using MRIs

published 1 day ago
(University of California - San Diego) In a paper published Sept. 17 in the online journal Magnetic Resonance in Medicine, researchers at the University of California, San Diego School of Medicine, University of Pittsburgh and elsewhere describe the first human tests of using a perfluorocarbon tracer in combination with non-invasive magnetic resonance imaging to track therapeutic immune cells injected into patients with colorectal cancer.

New cancer drug target involving lipid chemical messengers

published 1 day ago
(University of Pennsylvania School of Medicine) More than half of human cancers have abnormally upregulated chemical signals related to lipid metabolism, yet how these signals are controlled during tumor formation is not fully understood. Researchers report that TIPE3, a newly described oncogenic protein, promotes cancer by targeting these pathways.

The war on leukemia: How the battle for cell production could be decisive

published 2 days ago
(University of Birmingham) A key step in understanding the nature of the fight for superiority between mutated genes and normal genes could lead to new therapies to combat leukaemia, say researchers from the University of Birmingham and Newcastle University.